Clinical Trial: National Cooperative Growth Study (NCGS) of Optimal Nutropin AQ and Nutropin Dosing in Pubertal Growth Hormone-Deficient (GHD) Patients

Study Status: Completed
Recruit Status: Completed
Study Type: Observational

Official Title: National Cooperative Growth Study (NCGS) of Optimal Nutropin AQ and Nutropin Dosing in Pubertal Growth Hormone-Deficient (GHD) Subjects

Brief Summary: This study is a multicenter, open-label, observational, postmarketing surveillance study that will collect information on the use of Genentech GH preparations to treat GH-deficient subjects with optimal GH dosing during puberty.

Detailed Summary:
Sponsor: Genentech, Inc.

Current Primary Outcome:

Original Primary Outcome:

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Genentech, Inc.

Dates:
Date Received: November 24, 2004
Date Started: February 2003
Date Completion:
Last Updated: November 11, 2010
Last Verified: November 2010